OPC-1085

Known as: OPC 1085, OPC1085 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-1978
0119741978

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Cardiac electrophysiologic action of a new beta-adrenergic blocking agent carteolol hydrochloride, or OPC-1085, was studied in… (More)
Is this relevant?
1977
1977
The pharmacokinetics of 5-(3-tert.-butylamino-2-hydroxy)-propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol hydrochloride… (More)
Is this relevant?
1977
1977
Effects of a newly synthesized beta-blocker, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril (OPC-1085) were… (More)
Is this relevant?
1977
1977
1. The antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (opc-1085) were… (More)
Is this relevant?
1977
1977
The kinetics (absorption, distribution and excretion) of carteolol were investigated after oral and intravenous administration to… (More)
Is this relevant?
1977
1977
The effects of carteolol, propranolol and alprenolol were studied by using spontaneously contracting atria, atrial muscle and… (More)
Is this relevant?
1976
1976
Distribution of a new beta-adrenergic blocking agent, 3H-carteolol in mice was studied by whole body autoradiography. The… (More)
Is this relevant?
1975
1975
Effects of a new beta-adrenergic blocking agent, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride… (More)
Is this relevant?
1974
1974
The beta-adrenergic blocking and hemodynamic properties of 5-(3-tert-butyl-amino-2-hydroxy) propoxy-3,4-dihydrocarbostyril… (More)
Is this relevant?